Literature DB >> 21488860

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP.

Monica Testoni, Ivo Kwee, Timothy C Greiner, Santiago Montes-Moreno, Julie Vose, Wing C Chan, Annalisa Chiappella, Luca Baldini, Andrés J M Ferreri, Gianluca Gaidano, Michael Mian, Emanuele Zucca, Francesco Bertoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21488860     DOI： 10.1111/j.1365-2141.2011.08675.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  18 in total

1.  Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma.

Authors:  Andrés E Quesada; L Jeffrey Medeiros; Parth A Desai; Pei Lin; Jason R Westin; Huda M Hawsawi; Peng Wei; Guilin Tang; Adam C Seegmiller; Nishitha M Reddy; C Cameron Yin; Wei Wang; Jie Xu; Roberto N Miranda; Zhuang Zuo; Shaoying Li
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

2.  Cross-platform assessment of genomic imbalance confirms the clinical relevance of genomic complexity and reveals loci with potential pathogenic roles in diffuse large B-cell lymphoma.

Authors:  Lizalynn M Dias; Venkata Thodima; Julia Friedman; Charles Ma; Asha Guttapalli; Geetu Mendiratta; Imran N Siddiqi; Sergei Syrbu; R S K Chaganti; Jane Houldsworth
Journal:  Leuk Lymphoma       Date:  2015-11-16

3.  The t(14;18)(q32;q21) with extra MYC signal - is it a gray zone lymphoma?

Authors:  Qin A Chang; Abdulraheem Qasem; Sheshadri Madhusudhana; Alexey Glazyrin
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice.

Authors:  Idoia García-Ramírez; Saber Tadros; Inés González-Herrero; Alberto Martín-Lorenzo; Guillermo Rodríguez-Hernández; Dalia Moore; Lucía Ruiz-Roca; Oscar Blanco; Diego Alonso-López; Javier De Las Rivas; Keenan Hartert; Romain Duval; David Klinkebiel; Martin Bast; Julie Vose; Matthew Lunning; Kai Fu; Timothy Greiner; Fernando Rodrigues-Lima; Rafael Jiménez; Francisco Javier García Criado; María Begoña García Cenador; Paul Brindle; Carolina Vicente-Dueñas; Ash Alizadeh; Isidro Sánchez-García; Michael R Green
Journal:  Blood       Date:  2017-03-13       Impact factor: 22.113

Review 5.  Management of Patients with MYC-Altered Lymphomas.

Authors:  Daniel J Landsburg
Journal:  Curr Hematol Malig Rep       Date:  2016-06       Impact factor: 3.952

6.  Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.

Authors:  Daniel J Landsburg; Marissa K Falkiewicz; Adam M Petrich; Benjamin A Chu; Amir Behdad; Shaoying Li; L Jeffrey Medeiros; Ryan D Cassaday; Nishitha M Reddy; Martin A Bast; Julie M Vose; Kimberly R Kruczek; Scott E Smith; Priyank Patel; Francisco Hernandez-Ilizaliturri; Reem Karmali; Saurabh Rajguru; David T Yang; Joseph J Maly; Kristie A Blum; Weiqiang Zhao; Charles Vanslambrouck; Chadi Nabhan
Journal:  Br J Haematol       Date:  2016-07-29       Impact factor: 6.998

7.  MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Authors:  Alexandra Valera; Armando López-Guillermo; Teresa Cardesa-Salzmann; Fina Climent; Eva González-Barca; Santiago Mercadal; Iñigo Espinosa; Silvana Novelli; Javier Briones; José L Mate; Olga Salamero; Juan M Sancho; Leonor Arenillas; Sergi Serrano; Nadina Erill; Daniel Martínez; Paola Castillo; Jordina Rovira; Antonio Martínez; Elias Campo; Luis Colomo
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

8.  Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.

Authors:  Carlo Valentino; Samantha Kendrick; Nathalie Johnson; Randy Gascoyne; Wing C Chan; Dennis Weisenburger; Rita Braziel; James R Cook; Raymond Tubbs; Elias Campo; Andreas Rosenwald; German Ott; Jan Delabie; Elaine Jaffe; Wenjun Zhang; Patrick Brunhoeber; Hiro Nitta; Tom Grogan; Lisa Rimsza
Journal:  Am J Clin Pathol       Date:  2013-02       Impact factor: 2.493

Review 9.  The impact of MYC rearrangements and "double hit" abnormalities in diffuse large B-cell lymphoma.

Authors:  Pei Lin; L Jeffrey Medeiros
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

10.  B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas.

Authors:  Shaoying Li; Adam C Seegmiller; Pei Lin; Xuan J Wang; Roberto N Miranda; Sharathkumar Bhagavathi; L Jeffrey Medeiros
Journal:  Mod Pathol       Date:  2014-08-08       Impact factor: 7.842
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.